CYP24A1 and nephrolithiasis: Our study conducted in 2 large and deeply phenotyped Swiss cohorts of kidney stone formers now reveals that the VMDR (and hence the activity of CYP24A1 inversely) is directly associated with urinary calcium, the key prolithogenic abnormality in kidney stone formers.